Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
AKLI

AKLI - Akili Inc Stock Price, Fair Value and News

$7.700.00 (0.00%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AKLI RSI Chart

Oct2024AprJul020406080

AKLI Valuation

Market Cap

605.9M

Price/Earnings (Trailing)

-12.48

Price/Sales (Trailing)

20.16

EV/EBITDA

-11.8

Price/Free Cashflow

-12.42

AKLI Price/Sales (Trailing)

2022202320240100200300400500

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AKLI Fundamentals

AKLI Revenue

Revenue (TTM)

1.7M

Rev. Growth (Yr)

266.86%

Rev. Growth (Qtr)

54.12%

202120222023202401M2M3M4M

AKLI Earnings

Earnings (TTM)

-48.5M

Earnings Growth (Yr)

52.86%

Earnings Growth (Qtr)

12.42%

2021202220232024-80M-60M-40M-20M0

AKLI Price Action

Last 30 days

2.4%

Last 90 days

48.3%

AKLI Profitability

Operating Margin

49.05%

EBT Margin

-2889.87%

Return on Equity

-96.69%

Return on Assets

-72.06%

Free Cashflow Yield

-8.05%

AKLI Financial Health

Current Ratio

5.8

AKLI Investor Care

Shares Dilution (1Y)

0.78%

Diluted EPS (TTM)

-0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20212022202301M2M3M4M
Net sales
YearQ1Q2Q3Q4
20240000
2023774.7K1.2M01.7M
2022484.3K430.5K376.8K323.0K
202102.8M1.7M538.0K
20200003.9M
AKLI
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEakiliinteractive.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES111

Akili Inc Frequently Asked Questions


What is the ticker symbol for Akili Inc? What does AKLI stand for in stocks?

AKLI is the stock ticker symbol of Akili Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Akili Inc (AKLI)?

As of Tue Jul 02 2024, market cap of Akili Inc is 605.87 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AKLI stock?

You can check AKLI's fair value in chart for subscribers.

Is Akili Inc a good stock to buy?

The fair value guage provides a quick view whether AKLI is over valued or under valued. Whether Akili Inc is cheap or expensive depends on the assumptions which impact Akili Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AKLI.

What is Akili Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jul 02 2024, AKLI's PE ratio (Price to Earnings) is -12.48 and Price to Sales (PS) ratio is 20.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AKLI PE ratio will change depending on the future growth rate expectations of investors.